-
KAUSKAS-100
Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures… -
KAUSKAS-200
Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures… -
KAUSKAS-50
Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures… -
KEIKAI
Monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over. This is only… -
LADIVIR
Lamivudine is indicated for the treatment of chronic hepatitis B in adults with: • compensated liver disease with evidence of active viral replication, persistently elevated… -
LAKCAY
Raloxifen is indicated for the treatment and prevention of osteoporosis in postmenopausal women. A significant reduction in the incidence of vertebral, but not hip fractures… -
LEFVOX-750
Treatment of infections caused by organisms sensitive to levofloxacin, such as: - Nosocomial pneumonia. - Community-acquired pneumonia due to methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae (including… -
LEVETRAL
Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed…